317 related articles for article (PubMed ID: 26812021)
1. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
Hall MJ; Obeid EI; Schwartz SC; Mantia-Smaldone G; Forman AD; Daly MB
Gynecol Oncol; 2016 Mar; 140(3):565-74. PubMed ID: 26812021
[TBL] [Abstract][Full Text] [Related]
2. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
3. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition in gynecologic cancers.
Daniels MS; Lu KH
Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
[TBL] [Abstract][Full Text] [Related]
5. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L
Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897
[TBL] [Abstract][Full Text] [Related]
6. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
Shulman LP
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
8. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
Lu KH
Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
[TBL] [Abstract][Full Text] [Related]
9. Management of genetic syndromes predisposing to gynecologic cancers.
Miesfeldt S; Lamb A; Duarte C
Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
[TBL] [Abstract][Full Text] [Related]
10. Hereditary gynecologic cancers.
Mutch D; Denny L; Quinn M;
Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
[No Abstract] [Full Text] [Related]
11. For Women, Lynch Syndrome Is About More than Colon Cancer.
Parker WM; Hennig K; Burton-Chase AM
Cancer Prev Res (Phila); 2019 Dec; 12(12):831-836. PubMed ID: 31554630
[TBL] [Abstract][Full Text] [Related]
12. Hereditary cancers in obstetrics and gynecology.
Swisher E
Clin Obstet Gynecol; 2001 Sep; 44(3):450-63. PubMed ID: 11685871
[TBL] [Abstract][Full Text] [Related]
13. Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
Howarth DR; Lum SS; Esquivel P; Garberoglio CA; Senthil M; Solomon NL
Am Surg; 2015 Oct; 81(10):941-4. PubMed ID: 26463285
[TBL] [Abstract][Full Text] [Related]
14. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
15. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
16. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
17. Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.
Davidson BA; Moorman PG
Expert Opin Drug Saf; 2014 Oct; 13(10):1375-82. PubMed ID: 25146351
[TBL] [Abstract][Full Text] [Related]
18. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
Ballinger LL
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
[TBL] [Abstract][Full Text] [Related]
19. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
LaDuca H; Polley EC; Yussuf A; Hoang L; Gutierrez S; Hart SN; Yadav S; Hu C; Na J; Goldgar DE; Fulk K; Smith LP; Horton C; Profato J; Pesaran T; Gau CL; Pronold M; Davis BT; Chao EC; Couch FJ; Dolinsky JS
Genet Med; 2020 Feb; 22(2):407-415. PubMed ID: 31406321
[TBL] [Abstract][Full Text] [Related]
20. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
